Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment
Gonadotropin-releasing hormone (GnRH) agonists, currently used in the treatment of advanced prostate cancer, have been described as a rare cause of pituitary apoplexy, a potentially life-threatening clinical condition. We report the case of a 69-year-old man with a known pituitary macroadenoma who w...
Main Authors: | Mariana Barbosa, Sílvia Paredes, Maria João Machado, Rui Almeida, Olinda Marques |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2020-06-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2020/1/EDM20-0018.xml |
Similar Items
-
Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01) -
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
by: Choi S, et al.
Published: (2011-12-01) -
Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01) -
Pituitary apoplexy
by: Salam Ranabir, et al.
Published: (2011-01-01) -
The acute stage of pituitary apoplexy complicated with sinusitis
by: Chiao-Zhu Li, et al.
Published: (2021-01-01)